59
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Characteristics of COPD patients initiating treatment with aclidinium or tiotropium in primary care in Catalonia: a population-based study

, , , &
Pages 1145-1152 | Published online: 12 Apr 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Evgeni Mekov, Marc Miravitlles & Rosen Petkov. (2020) Artificial intelligence and machine learning in respiratory medicine. Expert Review of Respiratory Medicine 14:6, pages 559-564.
Read now
Fuyuan Li & Junyi Yang. (2019) Revefenacin for the treatment of chronic obstructive pulmonary disease. Expert Review of Clinical Pharmacology 12:4, pages 293-298.
Read now
Alejandro Casas, Maria Montes de Oca, Ana MB Menezes, Fernando C Wehrmeister, Maria Victorina Lopez Varela, Laura Mendoza, Larissa Ramírez & Marc Miravitlles. (2018) Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1545-1556.
Read now

Articles from other publishers (8)

Mònica Monteagudo, Miriam Barrecheguren, Iryna Solntseva, Nafeesa Dhalwani, Alison Booth, Alexa Nuñez, Dimitra Lambrelli & Marc Miravitlles. (2021) Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD. npj Primary Care Respiratory Medicine 31:1.
Crossref
Mònica Monteagudo, Alexa Nuñez, Iryna Solntseva, Nafeesa Dhalwani, Alison Booth, Miriam Barrecheguren, Dimitra Lambrelli & Marc Miravitlles. (2021) Treatment Pathways Before and After Triple Therapy in COPD: A Population-based Study in Primary Care in Spain. Archivos de Bronconeumología 57:3, pages 205-213.
Crossref
Mònica Monteagudo, Alexa Nuñez, Iryna Solntseva, Nafeesa Dhalwani, Alison Booth, Miriam Barrecheguren, Dimitra Lambrelli & Marc Miravitlles. (2021) Treatment Pathways Before and After Triple Therapy in COPD: A Population-based Study in Primary Care in Spain. Archivos de Bronconeumología (English Edition) 57:3, pages 205-213.
Crossref
Marc Miravitlles, Mònica Monteagudo, Iryna Solntseva & Bernardino Alcázar. (2021) Blood Eosinophil Counts and Their Variability and Risk of Exacerbations in COPD: A Population-Based Study. Archivos de Bronconeumología 57:1, pages 13-20.
Crossref
Marc Miravitlles, Mònica Monteagudo, Iryna Solntseva & Bernardino Alcázar. (2021) Blood Eosinophil Counts and Their Variability and Risk of Exacerbations in COPD: A Population-Based Study. Archivos de Bronconeumología (English Edition) 57:1, pages 13-20.
Crossref
F. Dalon, E. Van Ganse, C. Correia Da Silva, G. Nachbaur, L. Saïl & M. Belhassen. (2019) Revue générale sur l’adhésion aux traitements inhalés de la BPCO. Revue des Maladies Respiratoires 36:7, pages 801-849.
Crossref
M. T. Driessen, J. Whalen, B. Seewoodharry Buguth, L. A. Vallejo-Aparicio, I. P. Naya, Y. Asukai, B. Alcázar-Navarrete, M. Miravitlles, F. García-Río & N. A. Risebrough. (2018) Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: a Spanish National Healthcare System perspective. Respiratory Research 19:1.
Crossref
Miriam Barrecheguren, Mónica Monteagudo & Marc Miravitlles. (2018) Population-based study of LAMA monotherapy effectiveness compared with LABA/LAMA as initial treatment for COPD in primary care. npj Primary Care Respiratory Medicine 28:1.
Crossref